Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN was delisted on the 3rd of October, 2022.
226 hedge funds and large institutions have $4.34B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2020 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 77 increasing their positions, 63 reducing their positions, and 15 closing their positions.
347% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 15
325% more call options, than puts
Call options by funds: $160M | Put options by funds: $37.7M
122% more capital invested
Capital invested by funds: $1.95B → $4.34B (+$2.39B)
60% more funds holding in top 10
Funds holding in top 10: 10 → 16 (+6)
29% more funds holding
Funds holding: 175 → 226 (+51)
22% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 63
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$52.2M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$30M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.9M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$29.1M |
| 5 |
SC
Samlyn Capital
New York
|
+$28.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$55.1M |
| 2 |
AC
Armistice Capital
New York
|
-$29.6M |
| 3 |
Holocene Advisors
New York
|
-$21.1M |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$18.5M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$15.8M |
BHVN Hedge Fund Activity: Q2 2020 in Review
226 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) for Q2 2020, worth a combined $4.34B — up 122% from $1.95B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new BHVN positions and 15 closed out — a net gain of 52 holders — while 77 added to existing stakes and 63 trimmed.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $52.2M. The largest seller was Wellington Management Group, cutting an estimated $55.1M.
- 226 institutional investors held Biohaven Pharmaceutical Holding Company Ltd. (BHVN) as of Q2 2020, up from 175 in Q1 2020.
- Funds reported $4.34B of Biohaven Pharmaceutical Holding Company Ltd. stock for Q2 2020, up 122% quarter-over-quarter.
- 67 funds opened new Biohaven Pharmaceutical Holding Company Ltd. positions in Q2 2020 and 15 closed out, a net change of +52 holders.
- The largest Biohaven Pharmaceutical Holding Company Ltd. buyer in Q2 2020 was Tang Capital Management, an estimated $52.2M added.
- The largest Biohaven Pharmaceutical Holding Company Ltd. seller in Q2 2020 was Wellington Management Group, an estimated $55.1M sold.
Based on aggregated 13F filings for Q2 2020.